Literature DB >> 16611028

Discovery of new small molecules and targets towards angiogenesis via chemical genomics approach.

Ho Jeong Kwon1.   

Abstract

Chemical genetics/genomics is an inter- and multi-disciplinary research engine, which utilizes small molecules to explore the function of genes and accelerate the drug discovery. Bioactive small molecules that are permeable to cellular membrane and bind to its cognate target protein can exert the phenotype changes of the cells or organisms. Functional target proteins of these small molecules have been successfully identified by affinity, genetics and genomics based target identification. The specific molecular recognition of small molecule with target protein has facilitated to decipher the mode of actions of small molecules and developed better drug based on their structure activity relationship. Based on this idea, we have applied chemical genomics to angiogenesis, a new blood vessel formation, resulting in the identification of new small molecules as well as targets. In this review, our application of chemical genomics towards a cellular phenotype, angiogenesis, will be demonstrated.

Mesh:

Substances:

Year:  2006        PMID: 16611028     DOI: 10.2174/138945006776359377

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  3 in total

1.  NNC 55-0396, a T-type Ca2+ channel inhibitor, inhibits angiogenesis via suppression of hypoxia-inducible factor-1α signal transduction.

Authors:  Ki Hyun Kim; Dongyoung Kim; Ju Yeol Park; Hye Jin Jung; Yong-Hee Cho; Hyoung Kyu Kim; Jin Han; Kang-Yell Choi; Ho Jeong Kwon
Journal:  J Mol Med (Berl)       Date:  2014-12-04       Impact factor: 4.599

2.  Combination of reverse and chemical genetic screens reveals angiogenesis inhibitors and targets.

Authors:  Mattias Kalén; Elisabet Wallgard; Noomi Asker; Aidas Nasevicius; Elisabet Athley; Erik Billgren; Jon D Larson; Shannon A Wadman; Elizabeth Norseng; Karl J Clark; Liqun He; Linda Karlsson-Lindahl; Ann-Katrin Häger; Holger Weber; Hellmut Augustin; Tore Samuelsson; Chelsy K Kemmet; Carly M Utesch; Jeffrey J Essner; Perry B Hackett; Mats Hellström
Journal:  Chem Biol       Date:  2009-04-24

Review 3.  Overexpression of hypoxia-inducible factor and metabolic pathways: possible targets of cancer.

Authors:  Davinder Singh; Rohit Arora; Pardeep Kaur; Balbir Singh; Rahul Mannan; Saroj Arora
Journal:  Cell Biosci       Date:  2017-11-13       Impact factor: 7.133

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.